can glp 1 cause vision problems GLP-1 Medications and Your Eye Health – Windsor Investigating Vision Changes Linked to

These actions are likely due to the potential of BPC-157 to simulate vasodilatation and angiogenesis (new blood vessel formation) due to its action on peptidergic growth factors such as endothelial growth factor, Consequently, the peptide has demonstrated significant protective effects against gastric mucosal injury in rat models

Available from: Del Bo C, Riso P, Gardana C, Brusamolino A, Battezzati A, Ciappellano S

So amino acids gets used up to make other peptides and other proteins that you need

Follow-up labs every few months confirm the protocol is working as intended

What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months